Extremes of glycemic control (HbA1c) increase hospitalization risk in diabetic hemodialysis patients in the USA

American Journal of Nephrology

Volumn 29, Issue 1, 2008, Pages 54-61

  Williams, M E ^a   Lacson Jr , E ^b   Teng, M ^b   Hakim, R M ^b   Lazarus, J M ^b  

^a JOSLIN DIABETES CENTER   (United States)

^b FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

Author keywords

Diabetes mellitus; End stage renal disease, hospitalization; Glycemic control

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DATA ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; UNITED STATES; VASCULAR ACCESS;

AGED; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; REGRESSION ANALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK; SEPSIS;

EID: 48749092369     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151276     Document Type: Article

References (46)

1. US Renal Data System, USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006.
2. Brownard B: Diabetes: changing the fate of diabetics in the dialysis unit. Blood Purif 2007;25:39-47.
3. Centers for Disease Control and Prevention: Incidence of end-stage renal disease among persons with diabetes - United States, 1990-2002. MMWR Morb Mortal Wkly Rep 2005;54:1097-1100.
4. Woodward RS, Schnitzler MA, Baty J: Incidence and cost of new onset diabetes mellitus among US wait-listed and transplanted renal allograft recipients. Am J Transplant 2003;3:590-598.
5. Williams ME, Lacson E Jr, Teng M: Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int 2006;70:1503-1509.
6. Oomichi T, Tmoto M, Tabata T, et al: Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis. Diabetes Care 2006;29:1496-1500.
7. Wu MS, Yu CC, Yang CW, et al: Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 1997;12:2105-2110.
8. Morioka T, Emoto M, Tahata T, et al: Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 2001;24:909-913.
9. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993;329:977-986.
10. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
11. Cook CB, Hentz JG, Tsui C, et al: Poor glycemic control increases the risk of hospitalization in urban African Americans with diabetes. Ethn Dis 2006;16:880-885.
12. McMurray SD, Johnson G, Davis S, et al: Diabetes education and care management significantly improve patient outcomes in the dialysis unit. Am J Kidney Dis 2002;40:566-575.
13. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2655.
14. Gaede P, Vedel P, Larsen N, et al: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393.
15. Marinopoulos S, Berkenblit G, Rami T, et al: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-431.
16. Kalantar-Zadeh K, Block G, Humphreys MH, et al: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808.
17. 1c in diabetes mellitus. N Engl J Med 1976;295:417-420.
18. 1c in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-278.
19. 1c in normal and diabetic subjects. J Clin Invest 1976;58:820-824.
20. 1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999;22:1785-1789.
21. Ahmann AJ: Guidelines and performance measures for diabetes. Am J Manag Care 2007;13(suppl 29):S41-S46.
22. American Diabetes Association: Standards of medical care in diabetes - 2007. Diabetes Care 2007;30(suppl 1):S4-S41.
23. 1c targets: a guidance statement from the American College of Physicians. Ann Intern Med 2007;147:417-422.
24. Saydeh SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-342.
25. Manske CL: Hyperglycemia and intensive glycemic control in diabetic patients with chronic renal disease. Am J Kidney Dis 1998;34(suppl 3):S157-S171.
26. KDOQI: KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(suppl 2):S1-S179.
27. Tzamaloukas AH, Murata GH, Zager PG: The relationship between glycemic control and morbidity and mortality for diabetics on dialysis. ASAIO J 1993;39:880-885.
28. Feldt-Rasmussen B: Is there a need to optimize glycemic control in hemodialyzed diabetic patients? Kidney Int 2006;70:1392-1394.
29. 1c and survival in maintenance hemodialysis patients. Diabetes Care 2007;30:1049-1055.
30. Jeffcoate SL: Diabetes control and complications: the role of glycated hemoglobin 25 years on. Diabet Med 2004;21:657-665.
31. 1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 2007;54:139-144.
32. Ansari A, Thomas S, Goldsmith D: Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis 2003;41:523-531.
33. Tascona DJ, Morton AR, Toffelmire EB, et al: Adequacy of glycemic control in hemodialysis patients with diabetes. Diabetes Care 2006;29:2247-2251.
34. Tuohy K Williams ME: Management of the Diabetic ESRD Patient. Dialysis and Transplantation. Philadelphia, Elsevier, 2005, pp 131-155.
35. Holt RIG, Gallen I: Editorial: time to move beyond glycosylated haemoglobin. Diabet Med 2004;21:655-656.
36. Inaba M, Okuno S, Kumeda Y, et al: Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007;18:896-903.
37. Joy MS, Cefalu WT, Hogan SL, et al: Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 2002;39:297-307.
38. 1c levels in patients with chronic renal failure on hemodialysis. Intern Med 1998;38:826-830.
39. Little RR, Tennill AL, Rohfing C: Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? Clin Chem 2002;48:784-786.
40. Uehlinger DE, Gotch FA, Sheiner LB: A pharmacodynamic model of erythropoietin therapy for uremic anemia. Clin Pharmacol Ther 1992;51:76-89.
41. 1c levels in patients with chronic renal failure on hemodialysis. Intern Med 1998;37:826-830.
42. 1c levels in diabetic subjects on hemodialysis. Kidney Int 2007;72:1-14.
43. 1c interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care 2001;24:20-23.
44. Shecter M, Bairey Merz CN, Paul-Labrador MJ, et al: Plasma apolipoprotein B levels predict platelet-dependent thrombosis in patient with coronary artery disease. Cardiology 1999;92:151-155.
45. Benfield T, Jensen JS, Nordestgaard BG: Influence of diabetes and hyperglycaemia on infectious disease hospitalizations and outcome. Diabetologia 2007;50:549-554.
46. Held C, Gerstein HC, Yusuf S, et al: Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 2007;115:1371-1375.